Cantor Fitzgerald’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
18,137
+5,288
+41% +$5.36M 0.25% 59
2025
Q4
$13.8M Sell
12,849
-53,017
-80% -$50.7M 0.21% 71
2025
Q3
$50.3M Buy
65,866
+42,346
+180% +$31.5M 0.49% 42
2025
Q2
$18.3M Buy
23,520
+11,634
+98% +$9.04M 0.32% 27
2025
Q1
$9.82M Buy
11,886
+7,340
+161% +$6.11M 0.2% 34
2024
Q4
$3.51M Buy
+4,546
New +$3.76M 0.07% 46
2024
Q3
Sell
-1,750
Closed -$1.58M 262
2024
Q2
$1.58M Buy
1,750
+489
+39% +$391K 0.31% 58
2024
Q1
$981K Sell
1,261
-456
-27% -$325K 0.23% 64
2023
Q4
$1M Sell
1,717
-16,022
-90% -$9.35M 0.21% 67
2023
Q3
$9.53M Buy
17,739
+16,335
+1,163% +$8.42M 0.25% 135
2023
Q2
$658K Buy
1,404
+638
+83% +$268K 0.02% 337
2023
Q1
$263K Buy
+766
New +$258K 0.01% 508
2022
Q3
Sell
-1,167
Closed -$378K 817
2022
Q2
$378K Sell
1,167
-1,008
-46% -$303K 0.01% 577
2022
Q1
$623K Buy
+2,175
New +$560K 0.05% 212

Other funds holding LLY

Cantor Fitzgerald's LLY Position: Q1 2026 in Review

Cantor Fitzgerald increased its Eli Lilly (LLY) stake by 41% in Q1 2026, buying an estimated $5.36M and bringing the position to 18,137 shares worth $16.7M. The position accounts for 0.25% of the portfolio, ranked #59.

Cantor Fitzgerald first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $50.3M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cantor Fitzgerald held 18,137 shares of Eli Lilly worth $16.7M as of Q1 2026.
  • Cantor Fitzgerald bought 5,288 Eli Lilly shares in Q1 2026, an estimated $5.36M.
  • Eli Lilly made up 0.25% of Cantor Fitzgerald's portfolio in Q1 2026, its #59 holding.
  • Cantor Fitzgerald first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
  • Cantor Fitzgerald's Eli Lilly position peaked at $50.3M in Q3 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cantor Fitzgerald's 13F filing for Q1 2026, filed 15 May 2026.